132 related articles for article (PubMed ID: 3709595)
1. Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients.
Gouyette A; Apchin A; Foka M; Richard JM
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):257-63. PubMed ID: 3709595
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
Belliveau JF; Posner MR; Ferrari L; Crabtree GW; Cummings FJ; Wiemann MC; O'Leary GP; Griffin H; Phaneuf MA; O'Rourke A
Cancer Treat Rep; 1986 Oct; 70(10):1215-7. PubMed ID: 3756943
[TBL] [Abstract][Full Text] [Related]
3. Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
Holding JD; Lindup WE; Bowdler DA; Siodlak MZ; Stell PM
Br J Clin Pharmacol; 1991 Aug; 32(2):173-9. PubMed ID: 1931468
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of intraperitoneal cisplatin.
Lopez JA; Krikorian JG; Reich SD; Smyth RD; Lee FH; Issell BF
Gynecol Oncol; 1985 Jan; 20(1):1-9. PubMed ID: 4038390
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer.
Sileni VC; Fosser V; Maggian P; Padula E; Beltrame M; Nicolini M; Arslan P
Cancer Chemother Pharmacol; 1992; 30(3):221-5. PubMed ID: 1628371
[TBL] [Abstract][Full Text] [Related]
6. Continuous infusion of high-dose cisplatin in children: pharmacokinetics of free and total platinum.
Bues-Charbit M; Gentet JC; Bernard JL; Breant V; Cano JP; Raybaud C
Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1649-52. PubMed ID: 3428333
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin.
Vermorken JB; van der Vijgh WJ; Klein I; Gall HE; van Groeningen CJ; Hart GA; Pinedo HM
Clin Pharmacol Ther; 1986 Feb; 39(2):136-44. PubMed ID: 3943271
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications.
Vermorken JB; van der Vijgh WJ; Klein I; Gall HE; Pinedo HM
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1069-74. PubMed ID: 6891650
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of cis-dichlorodiammineplatinum.
Gormley PE; Bull JM; LeRoy AF; Cysyk R
Clin Pharmacol Ther; 1979 Mar; 25(3):351-7. PubMed ID: 761445
[TBL] [Abstract][Full Text] [Related]
10. Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation.
Los G; Blommaert fA; Barton R; Heath DD; den Engelse L; Hanchett C; Vicario D; Weisman R; Robbins KT; Howell SB
Cancer Chemother Pharmacol; 1995; 37(1-2):150-4. PubMed ID: 7497585
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic study of cisplatin and sodium thiosulfate in two-route-infusion chemotherapy].
Ikeda K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1026-31. PubMed ID: 3963847
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of cisplatin and the effect of sodium thiosulfate].
Hayata S; Hitoshi T; Kiyokawa K; Esaki S; Mihashi S; Hirano M
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2356-61. PubMed ID: 6541891
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.
Vermorken JB; van der Vijgh WJ; Klein I; Hart AA; Gall HE; Pinedo HM
Cancer Treat Rep; 1984 Mar; 68(3):505-13. PubMed ID: 6538459
[TBL] [Abstract][Full Text] [Related]
14. Clinical responses and platinum concentrations in tumors after intra-arterial and intravenous administration of cisplatin in the same patients with cervical cancer.
Kanamori Y; Kigawa J; Minagawa Y; Irie T; Itamochi H; Cheng X; Okada M; Terakawa N
Gynecol Obstet Invest; 1997; 44(1):57-60. PubMed ID: 9251956
[TBL] [Abstract][Full Text] [Related]
15. Clinical kinetics on intact cisplatin and some related species.
Himmelstein KJ; Patton TF; Belt RJ; Taylor S; Repta AJ; Sternson LA
Clin Pharmacol Ther; 1981 May; 29(5):658-64. PubMed ID: 7194166
[TBL] [Abstract][Full Text] [Related]
16. Tumor concentration of platinum in patients with head and neck cancer.
Mattox DE; Sternson LA; Von Hoff DD; Kuhn JG; Repta AJ
Otolaryngol Head Neck Surg; 1983 Jun; 91(3):271-5. PubMed ID: 6410327
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)].
von Heyden HW; Henkel H; Nagel GA; Weinstock N
Klin Wochenschr; 1982 Mar; 60(5):247-55. PubMed ID: 7200547
[TBL] [Abstract][Full Text] [Related]
18. Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases.
Civalleri D; Esposito M; Fulco RA; Vannozzi M; Balletto N; De Cian F; Percivale PL; Merlo F
Cancer; 1991 Sep; 68(5):988-94. PubMed ID: 1913493
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model.
Dzodic R; Gomez-Abuin G; Rougier P; Bonnay M; Ardouin P; Gouyette A; Rixe O; Ducreux M; Munck JN
Anticancer Drugs; 2004 Jul; 15(6):647-50. PubMed ID: 15205611
[TBL] [Abstract][Full Text] [Related]
20. Disposition of total and free cisplatin on two consecutive treatment cycles in patients with ovarian cancer.
Erlichman C; Soldin SJ; Thiessen JJ; Sturgeon JF; Fine S
Cancer Chemother Pharmacol; 1987; 19(1):75-9. PubMed ID: 3815729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
